Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan

This publication has 14 references indexed in Scilit:

• Protective Levels of Diphtheria-Neutralizing Antibody Induced in Healthy Volunteers by Unilateral Priming-Boosting Intranasal Immunization Associated with Restricted Ipsilateral Mucosal Secretory Immunoglobulin A
  Infection and Immunity, 2003
• Immunization withHaemophilus influenzaeType b–CRM₁₉₇Conjugate Vaccine Elicits a Mixed Th1 and Th2 CD4⁺T Cell Cytokine Response That Correlates with the Isotype of Antipolysaccharide Antibody
  The Journal of Infectious Diseases, 2001
• A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery
  Vaccine, 2000
• The sero-epidemiology of diphtheria in Western Europe
  Epidemiology and Infection, 2000
• Implications of the Diphtheria Epidemic in the Former Soviet Union for Immunization Programs
  The Journal of Infectious Diseases, 2000
• Mucosal immunity and tolerance: relevance to vaccine development
  Immunological Reviews, 1999
• The expanding universe of T-cell subsets: Th1, Th2 and more
  Published by Elsevier ,1999
• Distinct T‐cell subtypes induced with whole cell and acellular pertussis vaccines in children
  Immunology, 1998
• Intranasal booster vaccination against diphtheria and tetanus in man
  Vaccine, 1997
• Chitin Biotechnology Applications
  Biotechnology Annual Review, 1996